echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 2nd home in the country! The drug, car-t-T therapy, is listed for sale.

    2nd home in the country! The drug, car-t-T therapy, is listed for sale.

    • Last Update: 2020-07-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On June 30, the application submitted by the drug Ming Juno for the listing of the Riquilensai injection (tentative) was accepted by CDE, which is the second domestic listing of CAR-T therapy after Fosun Kate Yijilirunrace.

    drug-focused technology, co-founded in 2016 by the drug Mingcon d'Or and Juno of the United States. On June 9,
    , the company had just completed a $100 million round B financing.
    Ricky Lesa (development code: JWCAR029) is a CAR-T therapy that targets CD19.
    currently has two CAR-T treatments available worldwide, Yescarta (Gilead/Fosun Kate) and Kymriah (Nova), all on CD19.
    2019, Yescarta and Kymriah generated global sales of approximately $456 million and $278 million, respectively.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.